Abivax phase 2b study results of obefazimod (ABX464) in ulcerative colitis published in the Lancet G
DGAP-News: ABIVAX / Key word(s): StudyAbivax phase 2b study results of obefazimod (ABX464) in ulcerative colitis published in the Lancet Gastroenterology & Hepatology 06.09.2022 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement.ABIVAX PHASE 2B STUDY RESULTS OF OBEFAZIMOD (ABX4...